Parade aims to feature only the best products and services. If you buy something via one o...
The invite to Aurangzeb Khan Khichi is the first from New Delhi to a Pakistani official si...
At least 39 people have been killed after two high-speed trains collided near Urda, Spain.
If the phrase “music festival” immediately conjures up visions of standing for eight hours...
Christmas movies are in full swing over at Great American Family and this weekend offers u...
Countries
Opinion
Abdul El-Sayed’s toxic ‘academic research’ reveals his anti-American Muslim supremacy
Broke, woke and armed with a crazy plan: Pay the lunatics running the asylum even more
-
Medscape ( Middle East ) 2025/6/24A post hoc analysis of the BEATcc trial showed that atezolizumab plus chemotherapy and bevacizumab provided clinical benefit regardless of P...
-
PR Newswire ( Middle East ) 2025/6/19LENEXA, Kan., June 19, 2025 /PRNewswire/ -- ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced int...
-
Medscape ( Middle East ) 2025/6/19Modulating microbiome composition after allogeneic hematopoietic stem cell transplantation may help oncologists prevent bloodstream infectio...
-
CBS News ( Middle East ) 2025/6/10Dr. Jon LaPook introduces us to the next frontier of cancer treatment: immunotherapy, in which the body's own immune system is genetically m...
-
CBS News ( Middle East ) 2025/6/10Dr. Jon LaPook introduces us to the next frontier of cancer treatment: immunotherapy, in which the body's own immune system is genetically m...
-
PR Newswire ( Middle East ) 2025/6/3Highly experienced biopharma executive Dr Cristina Csimma joins Asgard's Board of Directors, while esteemed immunologists Prof Ignacio Meler...
- PR Newswire ( Middle East ) 2025/6/1
SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutica...
-
Independent ( Yemen ) 2025/5/31A new study found the drug kept head and neck cancers at bay for five years compared to 30 months with standard care
- PR Newswire ( Middle East ) 2025/5/15
Dark genome biotech RyboDyn deepens partnership with world-leading cancer immunotherapy center to validate novel oncology targets and advanc...
- Medscape ( Middle East ) 2025/5/5
Patients who were most likely to discontinue therapy had allergy to milk, sesame, and egg — all of which were associated with higher severe...
- PR Newswire ( Middle East ) 2025/5/2
KING OF PRUSSIA, Pa., May 1, 2025 /PRNewswire/ -- SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech fo...
- Medscape ( Middle East ) 2025/4/30
Neoadjuvant PD-1 blockade in early-stage mismatch repair–deficient solid rectal and non-rectal tumors can eliminate the need for surgery in...
- PRESSBEE ( Middle East ) 2025/4/29
Immunotherapy represents a significant advancement in the treatment of cancer, providing patients with less invasive options compared to tra...
- Medscape ( Middle East ) 2025/4/25
Treatment shows improved quality-of-life measures and significant immunological changes. Medscape Medical News
- Medscape ( Middle East ) 2025/4/23
NICE has approved nivolumab plus ipilimumab for NHS use in patients with aggressive colorectal cancer, following new evidence of clinical be...
